Prostate Cancer Ranks Second Among Men Globally; Early Screening Key for Those with Family History

Prostate cancer ranks as the second most common cancer in men worldwide, yet early stages usually show no symptoms, making timely screening vital. The World Cancer Research Fund reports it is also the fourth most common cancer overall. A family history—particularly a father or brother diagnosed at a young age or multiple close relatives—significantly raises a man's risk, prompting doctors to consider earlier PSA testing. For men at average risk, doctors typically start PSA‑based discussions around age 50; those with a first‑degree relative may begin at 45 or sooner, depending on the family pattern. PSA is a simple blood test that measures a protein produced by prostate cells, but elevated levels can stem from benign enlargement, prostatitis, infections, certain medicines, or cancer. An abnormal result leads doctors to repeat the test, evaluate symptoms, perform a digital rectal exam, and possibly order a multiparametric MRI or biopsy for confirmation. Benign prostatic hyperplasia and cancer share urinary symptoms such as weak flow, frequent nighttime urination, urgency, or a feeling of incomplete bladder emptying; blood in urine or semen and persistent pelvic pain also warrant assessment. When cancer is low‑risk and slow‑growing, active surveillance—regular PSA checks, exams, imaging, and occasional biopsies—offers a safe alternative to immediate surgery or radiation. Treatment choices, ranging from prostatectomy to external‑beam radiation, brachytherapy, or hormone therapy, depend on cancer grade, stage, patient age, health, and personal preference, and each carries potential side effects that can be mitigated with pelvic‑floor exercises, continence support, and counseling. Family members can aid by tracking appointments, results, and encouraging open dialogue about urinary and sexual health. ## Context Prostate cancer’s high global prevalence makes early detection a public‑health priority, and guidelines now advise men with a strong family history to start screening earlier than the general population.